Nokota Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,162,000
Closed -$102M 72
2016
Q3
$102M Buy
3,162,000
+1,054,000
+50% +$35.2M 1.76% 14
2016
Q2
$70.4M Buy
2,108,000
+527,000
+33% +$16.8M 2.64% 6
2016
Q1
$44.5M Buy
+1,581,000
New +$45.2M 1.94% 10

Other funds holding PFE

Nokota Management's PFE Position: Q4 2017 in Review

Nokota Management sold out of Pfizer (PFE) in Q4 2017, closing a stake of 582,994 shares — an estimated $19.7M sold.

Nokota Management first reported a position in PFE in Q3 2016 and held it in 5 quarters. The position peaked at $25.2M in Q1 2017. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Nokota Management reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
  • Nokota Management sold 582,994 Pfizer shares in Q4 2017, an estimated $19.7M.
  • Nokota Management first reported a position in Pfizer in Q3 2016 and held it in 5 quarters.
  • Nokota Management's Pfizer position peaked at $25.2M in Q1 2017.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Nokota Management's 13F filing for Q4 2017, filed 14 Feb 2018.